日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prescription and use of psychoactive medications among cancer patients and associated factors in lower and upper middle-income countries: systematic review

中低收入和中高收入国家癌症患者精神活性药物的处方和使用及其相关因素：系统评价

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-025-10272-8
Merabtine, Tassadit; Gnonlonfoun, Dieu Donné; Marcellaud, Elodie; Altayyar, Sarah; Tarhini, Zeinab; Christou, Niki; Jost, Jeremy
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study

亚临床原发性醛固酮增多症与主要不良心血管事件：一项基于人群的纵向队列研究

期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.124.073507
Goupil, Rémi; Desbiens, Louis-Charles; Merabtine, Amel; Agharazii, Mohsen; Madore, François; Vaidya, Anand; Leung, Alexander A; Kline, Gregory A; Shaw, Julie L V; Ramsay, Tim; Nadeau-Fredette, Annie-Claire; Sood, Manish M; Hundemer, Gregory L
免疫/内分泌
醛固酮增多症
发表日期：2025
文献求助 收藏

Revisiting Unattended Versus Attended Automated Office Blood Pressure Measurements: A Systematic Review and Meta-Analysis

重新审视无人值守与有人值守的自动诊室血压测量：系统评价和荟萃分析

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.125.042797
Deragon, Valérie; Baati, Youssef; Trudelle, Laurence; Merabtine, Amel; Chapman, Niamh; Picone, Dean S; Goupil, Rémi
发表日期：2025
文献求助 收藏

Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: feasibility study (RETAME-PA) - a clinical research protocol for a randomised controlled trial

肾素指导的盐皮质激素受体拮抗剂治疗原发性醛固酮增多症：可行性研究（RETAME-PA）——一项随机对照试验的临床研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-111167
Merabtine, Amel; Leung, Alexander A; Kline, Gregory A; Dubrofsky, Lisa; Hundemer, Gregory L; Goupil, Rémi
醛固酮增多症
信号转导
RET
免疫/内分泌
发表日期：2025
文献求助 收藏